2026. CHITOSAN NANOPARTICLES FOR NASAL DELIVERY OF ANTI-TUBERCULOSIS DRUGS: A NOVEL NON-INVASIVE APPROACH. Bioscience Insights. 3, 02 (Aug. 2026), 893–906.